European journal of obstetrics, gynecology, and reproductive biology · 2026
Reassessing the age distribution of vulvar lichen sclerosus: A retrospective cohort study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kreichman Evgeny, Raviv Oshrat, Solnica Amy, Reichman Orna
Аннотация
OBJECTIVE: Vulvar lichen sclerosus (vLS) is widely reported to affect postmenopausal women and premenarchal girls; however, literature is limited and largely based on histopathologic diagnosis, despite the fact that diagnosis is primarily clinical. We hypothesize that the age distribution of women diagnosed with vLS in a real-world clinical setting, where diagnosis is primarily clinical, is not bimodal and includes a substantial proportion of reproductive-age women.
METHODS: Retrospective cohort study of all women diagnosed with vLS at a vulvovaginal referral clinic between January 2014 and December 2024. The primary outcome was the age distribution of vLS. Secondary outcomes included comorbidities, symptoms, clinical features, and treatment response.
RESULTS: Among 4,480 women evaluated, 319 (7.1 %) were diagnosed with vLS. Mean age at diagnosis was 45 (±18.3) years. Age distribution did not significantly differ from a uniform distribution (p = 0.99). Classic anatomical features were present in 92 % and 87 % women were symptomatic, with pruritus (76.5 %) and dyspareunia (39.4 %) predominating. Among 214 women diagnosed at first visit, 171 (80 %) returned for follow-up; 94 % reported clinical improvement, with 74.5 % achieving ≥ 80 % symptom reduction, primarily following corticosteroids.
CONCLUSION: The age distribution of vLS cases was approximately uniform across adulthood. Clinicians should maintain diagnostic vigilance in reproductive-aged women.
METHODS: Retrospective cohort study of all women diagnosed with vLS at a vulvovaginal referral clinic between January 2014 and December 2024. The primary outcome was the age distribution of vLS. Secondary outcomes included comorbidities, symptoms, clinical features, and treatment response.
RESULTS: Among 4,480 women evaluated, 319 (7.1 %) were diagnosed with vLS. Mean age at diagnosis was 45 (±18.3) years. Age distribution did not significantly differ from a uniform distribution (p = 0.99). Classic anatomical features were present in 92 % and 87 % women were symptomatic, with pruritus (76.5 %) and dyspareunia (39.4 %) predominating. Among 214 women diagnosed at first visit, 171 (80 %) returned for follow-up; 94 % reported clinical improvement, with 74.5 % achieving ≥ 80 % symptom reduction, primarily following corticosteroids.
CONCLUSION: The age distribution of vLS cases was approximately uniform across adulthood. Clinicians should maintain diagnostic vigilance in reproductive-aged women.